Rxo (RXO) Share-based Compensation (2021 - 2026)

Rxo (RXO) has reported Share-based Compensation for 6 consecutive years, with $10.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 100.0% year-over-year to $10.0 million; the trailing twelve-month figure through Jun 2026 stood at $26.0 million (up 750.0% YoY), and the FY2025 full-year result was $29.0 million, up 26.09% from the prior year.
• Share-based Compensation rose to $10.0 million in Q2 2026 per RXO's latest filing, from $9.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $48.0 million in Q3 2024 and bottomed at -$74.0 million in Q4 2024.
• Historically, Share-based Compensation has averaged $6.8 million across 5 years, with a median of $13.0 million in 2023.
• The widest YoY moves for Share-based Compensation: up 300.0% in 2023, down 192.86% in 2023.
• Over 5 years, Share-based Compensation stood at -$14.0 million in 2022, then slumped by 192.86% to -$41.0 million in 2023, then tumbled by 80.49% to -$74.0 million in 2024, then soared by 87.84% to -$9.0 million in 2025, then surged by 211.11% to $10.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $10.0 million, $9.0 million, and -$9.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.